The phase diagram of the system Sr–Cu–O has been determined at 1173 K. Several compositions in the ternary system were quenched after equilibration, and the phases present were identified by optical microscopy, X‐ray diffraction, and electron proble microanalysis. Four ternary compounds, SrCu 2 O 2 , Sr 2 CuO 3 , SrCuO 2+δ , and Sr 14 Cu 24 O 41 , have been identified. Values for the nonstoichiometric parameter δ in SrCuO 2+δ corresponding to the different three‐phase fields have been determined using the hydrogen reduction technique. The thermodynamic properties of all the ternary oxides were determined using solidstate cells incorporating either oxide or fluoride electrolyte. The results from both types of cells were internally consistent. A discrepancy in the recent literature regarding thermodynamic properties of Sr 2 CuO 3 has been resolved. The compound Sr 14 Cu 24 O 41 has been identified in some of the earlier investigations as Sr 3 Cu 5 O 8+z˙ Using a novel variation of the galvanic cell technique, in which the emf of a cell incorporating a fluoride electrolyte is measured as a function of oxygen potential of the gas phase in equilibrium with the condensed phase electrode, the formula Sr 14 Cu 24 O 41 has been confirmed. The compound does not have significant nonstoichiometry. The phase relations in the system Sr–Cu–O have been evaluated as a function of temperature and oxygen partial pressure from the thermodynamic data.
No takes yet. Share an insight, caveat, or question.
Jacob et al. (1992) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: